ESMO Press Releases

If you require further information regarding any of the press releases listed below, please do not hesitate to contact us (select 'Press & Media').

Filter

Date Title Topic
09 Sep 2017 ESMO 2017 Press Release: Study Identifies Factors that Limit Work Ability of Young Adult Cancer Survivors
08 Sep 2017 ESMO 2017 Press Release: DNA Sequencing Could Open Up New Drug Indications for Patients with Rare Cancers Translational research
08 Sep 2017 ESMO 2017 Press Release: LORELEI: Taselisib Boosts Breast Tumor Shrinkage Breast cancer
08 Sep 2017 ESMO 2017 Press Release: New Data Confirms Superiority of Docetaxel Based Triplet Therapy in Gastric Cancer Gastrointestinal cancers
08 Sep 2017 ESMO 2017 Press Release: Pembrolizumab: Promising Response Rate in Pretreated Metastatic Gastric Cancer Gastrointestinal cancers
08 Sep 2017 ESMO 2017 Press Release: Patients with High Risk Prostate Cancer May Benefit “Equally” From Two New Treatments Genitourinary cancers
08 Sep 2017 ESMO 2017 Press Release: Rucaparib Boosts Progression-free Survival in BRCA Mutant Recurrent Ovarian Cancer Gynaecologic malignancies
07 Sep 2017 ESMO 2017 Media Alert: Get ready for ESMO 2017: Nearly 23,000 Participants Set to Attend
07 Sep 2017 ESMO 2017 Media Alert: Challenges Faced by Adolescent and Young Adult Cancer Patients: Press Conference at the ESMO 2017 Congress
07 Sep 2017 ESMO 2017 Media Alert: Incoming Wave of Biosimilars in Oncology: Special Session at ESMO 2017
06 Sep 2017 ESMO 2017 Press Release: Some Stroke Survivors May Have Underlying Cancer Epidemiology/Etiology/Cancer Prevention
06 Sep 2017 ESMO 2017 Press Release: Alectinib: ALEX and ALUR Trials Show CNS Benefit in NSCLC Lung and other thoracic tumours
05 Sep 2017 ESMO 2017 Press Release: MIRO Trial: 3-year Outcomes Favour Laparoscopic Surgery for Oesophageal Cancer Gastrointestinal cancers
04 Sep 2017 ESMO 2017 Press Release: ICON8 Trial Reaffirms Standard Dosing in Ovarian Cancer Chemo Gynaecologic malignancies
03 Sep 2017 ESMO 2017 Press Release: Study in Early Stage Breast Cancer Shows That Even Small Tumours Can Be Aggressive Breast cancer